Rapport Therapeutics, Inc. (RAPP)

SEC filing

Rapport Therapeutics, Inc.

RAPP · CIK 2012593

4 · Sep 24, 2026 · Director, Chief Executive Officer Ceesay Abraham sold 2,210 shares at $39.17/share ($86,565)

Director, Chief Executive Officer Ceesay Abraham sold 2,210 shares at $39.17/share ($86,565)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).